Migdal Insurance & Financial Holdings’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-375
Closed -$12K 520
2022
Q2
$12K Sell
375
-17,376
-98% -$608K ﹤0.01% 505
2022
Q1
$815K Sell
17,751
-1,341
-7% -$63.9K 0.01% 196
2021
Q4
$1.17M Sell
19,092
-1,707
-8% -$118K 0.01% 187
2021
Q3
$1.55M Buy
20,799
+1,243
+6% +$104K 0.02% 189
2021
Q2
$1.81M Buy
19,556
+1,904
+11% +$162K 0.02% 196
2021
Q1
$1.57M Buy
17,652
+1,608
+10% +$160K 0.02% 211
2020
Q4
$1.5M Buy
16,044
+151
+1% +$12K 0.02% 164
2020
Q3
$1.01M Buy
15,893
+7,399
+87% +$434K 0.01% 288
2020
Q2
$429K Buy
8,494
+804
+10% +$34.5K 0.01% 307
2020
Q1
$241K Buy
7,690
+1,942
+34% +$64.9K 0.01% 296
2019
Q4
$193K Buy
5,748
+638
+12% +$20.3K ﹤0.01% 421
2019
Q3
$150K Buy
5,110
+1,735
+51% +$56.4K ﹤0.01% 506
2019
Q2
$116K Buy
3,375
+1,332
+65% +$42.7K ﹤0.01% 552
2019
Q1
$67K Buy
+2,043
New +$60.3K ﹤0.01% 551

Other funds holding ARKG

Migdal Insurance & Financial Holdings's ARKG Position: Q3 2022 in Review

Migdal Insurance & Financial Holdings sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2022, closing a stake of 375 shares — an estimated $12K sold.

Migdal Insurance & Financial Holdings first reported a position in ARKG in Q1 2019 and held it in 14 quarters. The position peaked at $1.81M in Q2 2021. 312 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.

  • Migdal Insurance & Financial Holdings reported no remaining ARK Genomic Revolution ETF position as of Q3 2022 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 375 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $12K.
  • Migdal Insurance & Financial Holdings first reported a position in ARK Genomic Revolution ETF in Q1 2019 and held it in 14 quarters.
  • Migdal Insurance & Financial Holdings's ARK Genomic Revolution ETF position peaked at $1.81M in Q2 2021.
  • 312 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q3 2022, filed 31 Oct 2022.